HIV News and Research

RSS

Widespread COVID-19 testing may be possible with new dried blood tests

Researchers have developed dried blood spot sample testing that could be instrumental in preventing the spread of SARS- CoV-2.

17 Nov 2020

Lower dairy intake may be beneficial for people with metabolic syndrome

Results from a new trial published by a team led by researchers at Fred Hutchinson Cancer Research Center suggests lower dairy intake may be beneficial for people with metabolic syndrome.

17 Nov 2020

Researchers report encouraging results from in vitro combination therapy against COVID-19

Researchers at Karolinska Institutet in Sweden report promising results from an in vitro combination therapy against COVID-19.

17 Nov 2020

Discovery of 'Achilles heel' in protein crucial to HIV virulence could lead to new class of drugs

The discovery of a potential "Achilles heel" in Nef, the protein that is crucial to HIV virulence and its capacity to trigger AIDS, paves the way for the development of a new class of drugs against the virus.

17 Nov 2020

Asymptomatic individuals mount polyfunctional antibody response to SARS-CoV-2

Researchers in France have conducted a study showing that people who are asymptomatic following infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19) – elicit a polyfunctional antibody response to the virus.

16 Nov 2020

First-ever phase 3 advanced anal cancer trial opens for patient enrollment

The first randomized phase 3 clinical trial ever to be conducted in patients with advanced cancer of the anal canal is now open and enrolling patients.

16 Nov 2020

Difference in antibody evolution could predict COVID-19 outcomes

For COVID-19, the difference between surviving and not surviving severe disease may be due to the quality, not the quantity, of the patients' antibody development and response, suggests a new Cell paper published by Galit Alter, PhD, a member of the Ragon Institute of MGH, MIT and Harvard.

16 Nov 2020

Dopamine-release mechanisms in the brain may play a major role in SARS-CoV-2 infection

The study, which appeared in the Journal of Taibah University Medical Sciences, shows that the SARS-CoV-2 may behave akin to the CNS pathogenic mechanism of JEV and HIV during the early stages of infection.

15 Nov 2020

High prevalence of cross-reactive anti-SARS-CoV-2 antibodies in sub-Saharan Africa

A recent study published in the International Journal of Infectious Diseases has explained the lower prevalence of coronavirus disease 2019 (COVID-19) in sub-Saharan Africa compared to that in the US, Europe, and Asia.

15 Nov 2020

MIT researchers unravel the molecular structure of key coronavirus protein

MIT chemists have determined the molecular structure of a protein found in the SARS-CoV-2 virus. This protein, called the envelope protein E, forms a cation-selective channel and plays a key role in the virus's ability to replicate itself and stimulate the host cell's inflammation response.

12 Nov 2020

Study demonstrates positive effects of ACA's Medicaid expansion on early cancer diagnosis

In an analysis published today in the American Journal of Preventive Medicine, researchers from the University of Pittsburgh Graduate School of Public Health demonstrate positive effects of the Affordable Care Act (ACA) Medicaid expansion on rates of early cancer diagnosis.

12 Nov 2020

COVID-19 treatments for people with early infection should be prioritized

COVID-19 treatments for people with early infection are needed urgently, according to a JAMA Viewpoint article by National Institute of Allergy and Infectious Diseases (NIAID) Director Anthony S. Fauci, M.D., and colleagues.

11 Nov 2020

Study: SphK2 enzyme regulates immune cell responses during viral infection

Viruses such as HIV, hepatitis B and hepatitis C evade or disrupt the immune system to create persistent infections.

11 Nov 2020

Cabotegravir highly effective in preventing HIV among women

UNAIDS has been strongly encouraged by groundbreaking new study results showing that the antiretroviral medicine cabotegravir administered by an injection every two months – prevents HIV among women.

10 Nov 2020

Promising new antivirals target arboviruses and SARS-CoV-2: Nodosome inhibitors

A new study describes two promising small molecules that inhibit a host cell factor, called nucleotide binding oligomerization domain-containing protein 2 (NOD2), that inhibits the replication and spread of many arboviruses. This could lead to the development of broad-spectrum antivirals. The study's findings have been published on the preprint server bioRxiv*.

10 Nov 2020

Trump’s anti-abortion zeal shook fragile health systems around the world

In Ethiopia, health clinics for teenagers once supported by U.S. foreign aid closed down. In Kenya, a decades-long effort to integrate HIV testing and family planning unraveled.

10 Nov 2020

UVA develops new method to understand how HIV begins the infection process

Scientists at the University of Virginia School of Medicine have developed a method to understand how HIV and other viruses first begin to infect our cells, and that could help us prevent COVID-19 and other diseases.

10 Nov 2020

Researchers shed new light on stigma and conspiracy theories about coronavirus

The World Health Organization calls the spread of false information about the coronavirus (COVID-19) an "infodemic," and the results are broadly visible across society.

10 Nov 2020

Trial results show CAB LA is more effective in preventing HIV acquisition in women

The HIV Prevention Trials Network study (HPTN 084) on the safety and efficacy of the long-acting injectable antiretroviral drug cabotegravir (CAB LA), for pre-exposure prophylaxis (PrEP) in HIV-uninfected women, was stopped early by the trial Data and Safety Monitoring Board (DSMB) as results showed CAB LA to be highly effective in preventing HIV acquisition.

10 Nov 2020

Lupus patients receiving prophylactic therapy are at high risk for adverse reactions

New research shows that adults with systemic lupus erythematosus, who receive trimethoprim-sulfamethoxazole (TMP-SMX), a prophylactic therapy to help prevent pneumocystis pneumonia, are at high risk for adverse reactions to the drug, particularly if they are also positive for anti-Smith (anti-Sm) antibodies.

6 Nov 2020

HIV News and Research

Widespread COVID-19 testing may be possible with new dried blood tests

Lower dairy intake may be beneficial for people with metabolic syndrome

Researchers report encouraging results from in vitro combination therapy against COVID-19

Discovery of 'Achilles heel' in protein crucial to HIV virulence could lead to new class of drugs

Asymptomatic individuals mount polyfunctional antibody response to SARS-CoV-2

First-ever phase 3 advanced anal cancer trial opens for patient enrollment

Difference in antibody evolution could predict COVID-19 outcomes

Dopamine-release mechanisms in the brain may play a major role in SARS-CoV-2 infection

High prevalence of cross-reactive anti-SARS-CoV-2 antibodies in sub-Saharan Africa

MIT researchers unravel the molecular structure of key coronavirus protein

Study demonstrates positive effects of ACA's Medicaid expansion on early cancer diagnosis

COVID-19 treatments for people with early infection should be prioritized

Study: SphK2 enzyme regulates immune cell responses during viral infection

Cabotegravir highly effective in preventing HIV among women

Promising new antivirals target arboviruses and SARS-CoV-2: Nodosome inhibitors

Trump’s anti-abortion zeal shook fragile health systems around the world

UVA develops new method to understand how HIV begins the infection process

Researchers shed new light on stigma and conspiracy theories about coronavirus

Trial results show CAB LA is more effective in preventing HIV acquisition in women

Lupus patients receiving prophylactic therapy are at high risk for adverse reactions

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News